This website uses cookies
More information
Business Air News Bulletin
Business Air News Bulletin
The monthly news publication for aviation professionals.

Why visit ACE ’24?

Related background information from the Handbook...
The monthly news publication for aviation professionals.

Request your printed copy

Pilot medical certificate to remain valid post-vaccine
The FAA has authorised pilots to receive the Pfizer COVID-19 vaccine, administered in two doses over a 21-day period, without compromising the validity of their pilot medical certificates. NBAA welcomes the news.

The NBAA has welcomed prompt action by FAA administrator Steve Dickson and acting Federal Air Surgeon Dr. Brett Wyrick to ensure pilots may be vaccinated against COVID-19 without risk to their medical certificate.

The Federal Drug Administration (FDA) issued emergency-use authorisation for Pfizer's COVID-19 vaccine on 11 December. In an order issued the next morning, the FAA authorised pilots to receive the Pfizer vaccine, administered in two doses over a 21-day period, without compromising the validity of their pilot medical certificates.

Without such an order, pilots receiving vaccines that have not received full FDA approval risk invalidating their certificate. The order also applies to air traffic control personnel, who are also subject to FAA medical clearance requirements.

“We are grateful to the FAA for taking this immediate and proactive step to address medical certification concerns related to COVID-19 vaccinations that will aid in keeping the aviation industry moving forward,” says NBAA president and CEO Ed Bolen. “Administrator Dickson's previous military and civilian aviation experience continues to offer him unique insights on pilot-focused challenges, which in this case have proven astute, and we thank him and his team for their foresight and action on this matter.”

The FAA order requires that pilots must refrain from flying for 48 hours after receiving each dose of the Pfizer vaccine, after which time they may return to duty. Similar mandatory waiting periods are in place for those receiving other vaccines, the FAA noted, including against tuberculosis and typhoid.

While the agency “anticipates taking no additional measures to ensure safety after the initial window for side effects closes,” the FAA emphasised its medical professionals “will continuously monitor the initial distribution of the novel vaccine and documented clinical results and will adjust these recommendations as needed.”

Co-developed with Germany's BioNTech, the Pfizer vaccine is the first COVID-19 vaccine to receive authorisation in the US, with a second vaccine from Moderna currently under FDA review. Initial clinical trials have shown both vaccines to be highly effective against the virus.

Other News
 
Organisations warn of budget harm to an essential American industry
March 18, 2024
NBAA Fuels the Future of advocacy with Cutter
March 11, 2024
The FAA reauthorisation bill passes from Senate to Congress
February 13, 2024
The NBAA lauds the Senate committee passage of the FAA reauthorisation bill, and urges Congress to act with urgency to move forward on the priorities and programmes identified in the legislation.
US Senate pushed to reauthorise the FAA
January 27, 2024
NBAA reaffirms call for long-term FAA reauthorisation bill
January 2, 2024
NBAA welcomes Guillermet's appointment to lead EASA
December 28, 2023